comparemela.com

Latest Breaking News On - Joel beatty - Page 2 : comparemela.com

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2023 Earnings Call Transcript

ACADIA Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.28 EPS, expectations were $0.32. ACADIA Pharmaceuticals Inc.

United-states
Japan
Toronto
Ontario
Canada
United-kingdom
American
Japanese
Mark-schneyer
Parag-meswani
Charles-duncan
Tessa-romero

vimarsana © 2020. All Rights Reserved.